Presence, activities, and molecular forms of cathepsin G, elastase, α1-antitrypsin, and α1-antichymotrypsin in bronchiectasis

Journal of Clinical Immunology

Volumn 15, Issue 1, 1995, Pages 27-34

  Sepper, Ruth ^a,b   Konttinen, Yrjö T ^a   Ingman, Tuula ^a   Sorsa, Timo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

1 antichymotrypsin; 1 antitrypsin; Bronchiectasis; bronchoalveolar lavage fluid; cathepsin G; polymorphonuclear leukocyte elastase

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ALPHA 1 ANTITRYPSIN; CATHEPSIN G; ELASTASE;

ADULT; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG LAVAGE; MALE; NEUTROPHIL; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ALPHA 1-ANTICHYMOTRYPSIN; ALPHA 1-ANTITRYPSIN; BLOTTING, WESTERN; BRONCHIECTASIS; BRONCHOALVEOLAR LAVAGE FLUID; CATHEPSINS; CHILD; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMAN; LEUKOCYTE ELASTASE; MALE; NEUTROPHILS; PANCREATIC ELASTASE; SERINE ENDOPEPTIDASES; SUPPORT, NON-U.S. GOV'T;

EID: 0028816887     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/BF01489487     Document Type: Article

References (58)

1. Natural history and clinical management of emphysema in patients with and without alpha 1-antitrypsin inhibitor deficiency
2. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis
3. Proteolytic enzymes, their inhibitors and lung diseases
4. The protease-antiprotease balance within the human lung: Implications for the pathogenesis of emphysema
5. Tissue destruction by neutrophils
6. Neutrophil function in chronic bronchitis
7. The response of patients with purulent bronchiectasis to antibiotics for four months
8. Bronchiectasis—New therapeutic approaches based on pathogenesis
9. Extracellular matrix injury during lung inflammation
10. Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis
11. Mucus hypersecretion in bronchiectasis. The role of neutrophil proteases
12. New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: Its role in lung disease
13. Elastolytic activity of sputum and its relation to purulence and to lung function in patients with bronchiectasis
14. Alpha-1-antitrypsin and leukocyte elastase in infected and noninfected sputum
15. Observations of development of resistance to detachment of cultured bovine bronchial epithelial cells in response to protease treatment
16. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells
17. Leukocyte elastase
18. Neutrophil proteinases. Caution signs in designing inhibitors against enzymes with possible multiple functions
19. The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan heterogeneity and the pathway of proteolytic degradation
20. The degradation of articular collagen by neutrophil proteinases
21. Human neutrophil elastase functions as a type III collagen “collagenase”
22. Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G
23. Degradation of type IV (basement membrane) collagen by a proteinase isolated from human polymorphonuclear leukocyte granules
24. Stimulation of the elastolytic activity of leukocyte elastase by leukocyte cathepsin G
25. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties
26. Additive enhancement of neutrophil collagenase activity by HOCl and cathepsin G
27. Activation of neutrophil collagenase by cathepsin G
28. α-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis
29. Human neutrophil elastase and elastase/alpha1-antiprotease complex in cystic fibrosis
30. Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III
31. Serum derived protease inhibitors and leucocyte elastase in sputum and the effect of infection
32. Bronchoalveolar lavage
33. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
34. Mapping of the extended substrate binding site of cathepsin G and human leukocyte elastase
35. The synthesis and analytical use of a highly sensitive and convenient substrate of elastase
36. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
37. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
38. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics
39. Tumor necrosis factor-alpha enhances platelet activation via cathepsin G released from neutrophils
40. Human leukocyte granule elastase: Rapid isolation and characterization
41. Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar macrophages from healthy smokers requires the presence of myeloperoxidase
42. Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions
43. In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes
44. Potential mediator of inflammation. Phagocytederived oxidants suppress the elastase-inhibitory capacity of alpha 1-proteinase inhibitor in vitro
45. Interaction of human alpha-1-proteinase inhibitor with neutrophil myeloperoxidase
46. Interstitial collagenase (matrix metallo-proteinase-1) expresses serpinase activity
47. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases
48. Physiology and pathophysiology of neutral proteinases of human granulocytes
49. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin
50. Kinetic and chemical evidence for the inability of oxidized alpha 1-proteinase inhibitor to protect lung elastin from elastolytic degradation
51. The degradation of human lung elastin by neutrophil proteinases
52. Effect of different elastase inhibitors on leukocyte elastase pre-adsorbed to elastin
53. Mechanism of interaction of bovine trypsin with human alpha 1-antitrypsin
54. Human alpha-1-antichymotrypsin: Interaction with chymotrypsin-like proteinases
55. Enzymatic inactivation of human plasma C1-inhibitor and alpha 1-antichymotrypsin by Pseudomonas aeruginosa proteinase and elastase
56. Alpha 1-Antichymotrypsin in lung secretions is not an effective proteinase inhibitor
57. Roles of mast cell tryptase and chymase in airway function
58. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide choloromethyl ketone and sulfonyl fluoride inhibitors